Study of Efficacy and Safety of Dabrafenib in Combination With Trametinib in Pediatric Patients With BRAF V600 Mutation Positive LGG or Relapsed or Refractory HGG Tumors
Novartis
Novartis
City of Hope Medical Center
Children's Oncology Group
National Institutes of Health Clinical Center (CC)